Humans to be genetically-modified in Europe for the first time this year using gene-splicing therapy

Humans to be genetically-modified in Europe for the first time this year using gene-splicing therapy

Europe will see its first genetically engineered patients using a groundbreaking gene-splicing therapy this year after regulators approved trials. The biotech company Crispr Therapeutics is hoping to cure the disease beta thalassaemia, a devastating blood disorder which reduces the production of haemoglobin, the protein which carries oxygen to cells. Without sufficient oxygen, sufferers can be left with bone deformities, severe anaemia, slow growth, fatigue and shortness of breath.

Continue reading…

More great content like this @ Science & Space Front Page or you can Request Invite

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s